{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:19:07Z","timestamp":1771665547486,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00467-023-05955-5","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T13:06:42Z","timestamp":1683551202000},"page":"3455-3464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes based on induction regimens in pediatric kidney transplantation: a NAPRTCS and PHIS collaborative study"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-3282","authenticated-orcid":false,"given":"Daniella Levy","family":"Erez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Rodig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Somers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the NAPRTCS investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"5955_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/tri.13079","volume":"31","author":"VR Dharnidharka","year":"2018","unstructured":"Dharnidharka VR, Naik AS, Axelrod DA, Schnitzler MA, Zhang Z, Bae S, Segev DL, Brennan DC, Alhamad T, Ouseph R, Lam NN, Nazzal M, Randall H, Kasiske BL, McAdams-Demarco M, Lentine KL (2018) Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice. Transpl Int 31:198\u2013211","journal-title":"Transpl Int"},{"key":"5955_CR2","volume":"25","author":"S Riad","year":"2021","unstructured":"Riad S, Jackson S, Chinnakotla S, Verghese P (2021) Primary pediatric live-donor-kidney transplant-recipient\u2019s outcomes by immunosuppression induction received in the United States. Pediatr Transplant 25:e13925","journal-title":"Pediatr Transplant"},{"key":"5955_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1399-3046.2007.00764.x","volume":"12","author":"PW Baron","year":"2008","unstructured":"Baron PW, Ojogho ON, Yorgin P, Sahney S, Cutler D, Ben-Youssef R, Baqai W, Weissman J, Franco E, Zuppan C, Concepcion W (2008) Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: a retrospective study. Pediatr Transplant 12:32\u201339","journal-title":"Pediatr Transplant"},{"key":"5955_CR4","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1097\/TP.0000000000001577","volume":"101","author":"CM Mincham","year":"2017","unstructured":"Mincham CM, Wong G, Teixeira-Pinto A, Kennedy S, Alexander S, Larkins N, Lim WH (2017) Induction therapy, rejection, and graft outcomes in pediatric and adolescent kidney transplant recipients. Transplantation 101:2146\u20132151","journal-title":"Transplantation"},{"key":"5955_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1097\/CCM.0000000000001837","volume":"44","author":"P Gupta","year":"2016","unstructured":"Gupta P, Richardson T, Hall M, Bertoch D, Hebbar KB, Fortenberry JD, Wetzel RC (2016) Effect of inhaled nitric oxide on outcomes in children with acute lung injury: propensity matched analysis from a linked database. Crit Care Med 44:1901\u20131909","journal-title":"Crit Care Med"},{"key":"5955_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00467-018-4183-0","volume":"34","author":"AC Redpath Mahon","year":"2019","unstructured":"Redpath Mahon AC, Richardson T, Neu AM, Warady BA,  SCOPE Investigators (2019) Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States. Pediatr Nephrol 34:1049\u20131055","journal-title":"Pediatr Nephrol"},{"key":"5955_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13379","volume":"23","author":"J Godown","year":"2019","unstructured":"Godown J, Hall M, Thompson B, Thurm C, Jabs K, Gillis LA, Hafberg ET, Alexopoulos S, Karp SJ, Soslow JH (2019) Expanding analytic possibilities in pediatric solid organ transplantation through linkage of administrative and clinical registry databases. Pediatr Transplant 23:e13379","journal-title":"Pediatr Transplant"},{"key":"5955_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/petr.12253","volume":"18","author":"K Supe-Markovina","year":"2014","unstructured":"Supe-Markovina K, Melquist JJ, Connolly D, DiCarlo HN, Waltzer WC, Fine RN, Darras FS (2014) Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience. Pediatr Transplant 18:363\u2013368","journal-title":"Pediatr Transplant"},{"key":"5955_CR9","doi-asserted-by":"publisher","unstructured":"Kaabak MM, Babenko NN, Shapiro R, Maschan AA, Zokoev AK, Schekaturov SV, Vyunkova JN, Dymova OV (2017) Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction. Pediatr Transplant 21(5):e12941.\u00a0https:\/\/doi.org\/10.1111\/petr.12941","DOI":"10.1111\/petr.12941"},{"key":"5955_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12882-020-01767-z","volume":"21","author":"M Guthoff","year":"2020","unstructured":"Guthoff M, Berger K, Althaus K, Muhlbacher T, Bakchoul T, Steurer W, Nadalin S, Konigsrainer A, Heyne N (2020) Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients. BMC Nephrol 21:178\u201320","journal-title":"BMC Nephrol"},{"key":"5955_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/TP.0000000000001416","volume":"101","author":"IK Kim","year":"2017","unstructured":"Kim IK, Choi J, Vo AA, Kang A, Patel M, Toyoda M, Mirocha J, Kamil ES, Cohen JL, Louie S, Galera O, Jordan SC, Puliyanda DP (2017) Safety and efficacy of alemtuzumab induction in highly sensitized pediatric renal transplant recipients. Transplantation 101:883\u2013889","journal-title":"Transplantation"},{"key":"5955_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1600-6143.2007.02017.x","volume":"8","author":"AA Vo","year":"2008","unstructured":"Vo AA, Wechsler EA, Wang J, Peng A, Toyoda M, Lukovsky M, Reinsmoen N, Jordan SC (2008) Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab. Am J Transplant 8:144\u2013149","journal-title":"Am J Transplant"},{"key":"5955_CR13","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/TP.0b013e3181fc8937","volume":"90","author":"L Li","year":"2010","unstructured":"Li L, Chaudhuri A, Chen A, Zhao X, Bezchinsky M, Concepcion W, Salvatierra O, Sarwal MM (2010) Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation. Transplantation 90:1516\u20131520","journal-title":"Transplantation"},{"key":"5955_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/petr.12374","volume":"18","author":"JK Warejko","year":"2014","unstructured":"Warejko JK, Hmiel SP (2014) Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization. Pediatr Transplant 18:816\u2013821","journal-title":"Pediatr Transplant"},{"key":"5955_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ajt.12572","volume":"14","author":"AI Sutherland","year":"2014","unstructured":"Sutherland AI, Akhtar MZ, Zilvetti M, Brockmann J, Ruse S, Fuggle SV, Sinha S, Harden P, Friend PJ (2014) Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study. Am J Transplant 14:677\u2013684","journal-title":"Am J Transplant"},{"key":"5955_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1600-6143.2009.02581.x","volume":"9","author":"SJ Knechtle","year":"2009","unstructured":"Knechtle SJ, Pascual J, Bloom DD, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Kwun J, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW (2009) Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. Am J Transplant 9:1087\u20131098","journal-title":"Am J Transplant"},{"key":"5955_CR17","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1111\/j.1600-6143.2005.01123.x","volume":"5","author":"SM Flechner","year":"2005","unstructured":"Flechner SM, Friend PJ, Brockmann J, Ismail HR, Zilvetti M, Goldfarb D, Modlin C, Mastroianni B, Savas K, Devaney A, Simmonds M, Cook DJ (2005) Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant 5:3009\u20133014","journal-title":"Am J Transplant"},{"key":"5955_CR18","first-page":"CD004759","volume":"1","author":"P Hill","year":"2017","unstructured":"Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC (2017) Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Cochrane Database Syst Rev 1:CD004759","journal-title":"Cochrane Database Syst Rev"},{"key":"5955_CR19","volume":"25","author":"S Riad","year":"2021","unstructured":"Riad S, Jackson S, Chinnakotla S, Verghese P (2021) Primary pediatric live-donor-kidney transplant-recipients\u2019 outcomes by immunosuppression induction received in the United States. Pediatr Transplant 25:e13925","journal-title":"Pediatr Transplant"},{"key":"5955_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1432-2277.2012.01448.x","volume":"25","author":"JC LaMattina","year":"2012","unstructured":"LaMattina JC, Mezrich JD, Hofmann RM, Foley DP, D\u2019Alessandro AM, Sollinger HW, Pirsch JD (2012) Alemtuzumab as compared to alternative contemporary induction regimens. Transpl Int 25:518\u2013526","journal-title":"Transpl Int"},{"key":"5955_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/TP.0b013e3181b4acfb","volume":"88","author":"AC Farney","year":"2009","unstructured":"Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ (2009) A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation 88:810\u2013819","journal-title":"Transplantation"},{"key":"5955_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.6002\/ect.2019.0041","volume":"18","author":"K Korneffel","year":"2020","unstructured":"Korneffel K, Gehring B, Rospert D, Rees M, Ortiz J (2020) BK virus in renal transplant patients using alemtuzumab for induction immunosuppression. Exp Clin Transplant 18:557\u2013563","journal-title":"Exp Clin Transplant"},{"key":"5955_CR23","volume":"25","author":"S Riad","year":"2021","unstructured":"Riad S, Jackson S, Chinnakotla S, Verghese P (2021) Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States. Pediatr Transplant 25:e13928","journal-title":"Pediatr Transplant"},{"key":"5955_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, Dohler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4:222\u2013230","journal-title":"Am J Transplant"},{"key":"5955_CR25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1399-3046.2005.00361.x","volume":"9","author":"VR Dharnidharka","year":"2005","unstructured":"Dharnidharka VR, Stevens G (2005) Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation. Pediatr Transplant 9:622\u2013626","journal-title":"Pediatr Transplant"}],"updated-by":[{"DOI":"10.1007\/s00467-023-06043-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000}}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-05955-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T14:09:30Z","timestamp":1693318170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-05955-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5955"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-05955-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00467-023-06043-4","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00467-023-06043-4","URL":"https:\/\/doi.org\/10.1007\/s00467-023-06043-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}